E. Young

发表

Revealing retroperitoneal liposarcoma morphology using optical coherence tomography.

Kirill V Larin, A. Lazar, R. Pollock, 2011, Journal of biomedical optics.

Histopathologic features of melanoma in difficult‐to‐diagnose lesions: A case‐control study

Katelyn A. McKenzie, M. Kucenic, V. Tonkovic-Capin, 2017, Journal of the American Academy of Dermatology.

Genome-wide in vivo RNAi screen identifies ITIH5 as a metastasis suppressor in pancreatic cancer

S. Natsugoe, T. Iwakuma, D. Welch, 2017, Clinical & Experimental Metastasis.

Targeting the PI 3 K / mTOR Axis , Alone and in Combination with Autophagy Blockade , for the Treatment of Malignant Peripheral Nerve Sheath Tumors

A. Lazar, R. Pollock, D. Lev, 2012 .

Targeting the PI3K/mTOR Axis, Alone and in Combination with Autophagy Blockade, for the Treatment of Malignant Peripheral Nerve Sheath Tumors

A. Lazar, R. Pollock, D. Lev, 2012, Molecular Cancer Therapeutics.

MiR-155 is a liposarcoma oncogene that targets casein kinase-1α and enhances β-catenin signaling.

C. Creighton, Matthew L. Anderson, A. Lazar, 2012, Cancer Research.

An experimental model for the study of well differentiated and dedifferentiated liposarcoma; deregulation of targetable tyrosine kinase receptors

A. Lazar, D. Lev, S. Bolshakov, 2010, Laboratory Investigation.

Autophagic survival in resistance to histone deacetylase inhibitors: novel strategies to treat malignant peripheral nerve sheath tumors.

A. Lazar, J. Slopis, D. McConkey, 2011, Cancer research.

Uterine Leiomyosarcoma Management, Outcome, and Associated Molecular Biomarkers: A Single Institution’s Experience

K. Hunt, C. Creighton, Matthew L. Anderson, 2013, Annals of Surgical Oncology.

Expression of ‘drugable’ tyrosine kinase receptors in malignant peripheral nerve sheath tumour: potential molecular therapeutic targets for a chemoresistant cancer

Kai Huang, Jun Liu, A. Lazar, 2011, Histopathology.

Progressive loss of myogenic differentiation in leiomyosarcoma has prognostic value

M. Rijn, G. Boland, A. Lazar, 2015, Histopathology.

Development and Notch Signaling Requirements of the Zebrafish Choroid Plexus

D. Balciunas, S. Ekker, V. Korzh, 2008, PloS one.

A. Lazar, R. Pollock, D. Lev, 2012, Histology and histopathology.

Ikk4a/Arf Inactivation with Activation of the NF-kB/IL-6 Pathway Is Sufficient to Drive the Development and Growth of Angiosarcoma

G. Ayers, A. Lazar, D. Lev, 2012 .

Clinicopathological variables of sporadic schwannomas of peripheral nerve in 291 patients and expression of biologically relevant markers.

A. Lazar, J. Slopis, R. Pollock, 2017, Journal of neurosurgery.

Heterogeneity and immunophenotypic plasticity of malignant cells in human liposarcomas.

A. Lazar, R. Pollock, D. Lev, 2013, Stem cell research.

Epithelioid sarcoma and unclassified sarcoma with epithelioid features: clinicopathological variables, molecular markers, and a new experimental model.

A. Lazar, R. Pollock, D. Lev, 2011, The oncologist.

Targeting the untargetable? Nodal expression in TNBC

D. Welch, E. Young, Danny R. Welch, 2016, Cell cycle.

Outcome comparison of in vitro fertilization treatment with highly purified subcutaneous follicle-stimulating hormone (Fertinex, a urofollitropin) versus intramuscular menotropins.

N. Steuerwald, E. Young, J. Crain, 1998, American journal of obstetrics and gynecology.

Survivin Is a Viable Target for the Treatment of Malignant Peripheral Nerve Sheath Tumors

C. Creighton, A. Lazar, Yiqun Zhang, 2012, Clinical Cancer Research.

Dual Targeting of mTOR and Aurora-A Kinase for the Treatment of Uterine Leiomyosarcoma

K. Hunt, C. Creighton, Kai Huang, 2012, Clinical Cancer Research.

Suppression of pancreatic cancer liver metastasis by secretion-deficient ITIH5

M. Hollingsworth, T. Iwakuma, M. O’Neil, 2020, British journal of cancer.

Pleomorphic liposarcoma

A. Lazar, R. Pollock, P. Pisters, 2011, Cancer.

Activated MET Is a Molecular Prognosticator and Potential Therapeutic Target for Malignant Peripheral Nerve Sheath Tumors

Jun Liu, A. Lazar, Quan-sheng Zhu, 2011, Clinical Cancer Research.

Human Cancer Biology Activated MET Is a Molecular Prognosticator and Potential Therapeutic Target for Malignant Peripheral Nerve Sheath Tumors

Jun Liu, A. Lazar, Quan-sheng Zhu, 2011 .

Combining EGFR and mTOR Blockade for the Treatment of Epithelioid Sarcoma

A. Lazar, Quan-sheng Zhu, D. Lev, 2011, Clinical Cancer Research.

INK4a/ARF [corrected] inactivation with activation of the NF-κB/IL-6 pathway is sufficient to drive the development and growth of angiosarcoma.

G. Ayers, A. Lazar, D. Lev, 2012, Cancer research.

The Role of Inter-Alpha-Trypsin-Inhibitor-Heavy-Chain-5 (ITIH5) in Suppressing Pancreatic Cancer Metastasis

E. Young, 2018 .

MiR-155 is a liposarcoma oncogene that targets casein kinase-1α and enhances β-catenin signaling.

Dina Lev, Chad J Creighton, C. Creighton, 2012, Cancer research.

Histologic variability in solitary fibrous tumors reflects angiogenic and growth factor signaling pathway alterations.

K. Aldape, P. Fox, K. Wani, 2015, Human pathology.

Automated quantitative image analysis for ex vivo metastasis assays reveals differing lung composition requirements for metastasis suppression by KISS1

D. Welch, E. Young, K. Strom, 2018, Clinical & Experimental Metastasis.

Line-scan Raman microscopy complements optical coherence tomography for tumor boundary detection

Kirill V. Larin, Raphael E. Pollock, Narendran Sudheendran, 2014 .

DNAJA1 promotes cancer metastasis through interaction with mutant p53

T. Iwakuma, A. Parrales, H. Harada, 2021, Oncogene.

MiR-155 is a liposarcoma oncogene that targets casein kinase-1α and enhances β-catenin signaling.

C. Creighton, Matthew L. Anderson, A. Lazar, 2012, Cancer research.

Heterogeneity and immunophenotypic plasticity of malignant cells in human liposarcomas.

A. Lazar, R. Pollock, D. Lev, 2013, Stem cell research.